Literature DB >> 13479034

The use of plasmin in humans.

E E CLIFFTON.   

Abstract

Entities:  

Keywords:  FIBRINOLYSIN

Mesh:

Substances:

Year:  1957        PMID: 13479034     DOI: 10.1111/j.1749-6632.1957.tb42627.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Mechanism of formation of vascular thrombosis and its treatment with fibrinolysin.

Authors:  E E CLIFFTON
Journal:  J Natl Med Assoc       Date:  1961-09       Impact factor: 1.798

2.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

3.  The present status of the clinical evaluation of fibrinolysin.

Authors:  R V CHAPPLE; H O SINGHER
Journal:  Can Med Assoc J       Date:  1959-08-15       Impact factor: 8.262

4.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

5.  Behavior in the circulation of the radioactive pulmonary embolus and its application to the study of fibrinolytic enzymes.

Authors:  M HUME; W W GLENN; T GRILLO
Journal:  Ann Surg       Date:  1960-04       Impact factor: 12.969

Review 6.  [Problems associated with transfusion of post mortem blood].

Authors:  P Volk; J G Gostomzyk; B Schäfer; R Reck
Journal:  Z Rechtsmed       Date:  1970

7.  Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition.

Authors:  Navneet Kaur; Prakash Kumar Sinha; Girish Sahni
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.